NeoGenomics Inc Cash Flow Reinvestment Rate
NeoGenomics Inc cash flow reinvestment rate. NeoGenomics Inc (NEO) has a Cash Flow Reinvestment Rate of 0.41x as of June 2026, reinvesting $8.22 Million (capex $8.22 Million ) from operating cash flow of $19.96 Million. Explore NeoGenomics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of NeoGenomics Inc (2011–2025)
Cash flow reinvestment rate of NeoGenomics Inc from 2011 to 2025. Historical reinvestment intensity for NeoGenomics Inc across 11 annual periods. Explore capital reinvestment ratio of NeoGenomics Inc to see what proportion of operating cash flow is directed to capital expenditures.
NeoGenomics Inc Cash Flow Reinvestment Rate by Year (2011–2025)
NeoGenomics Inc cash flow reinvestment rate by year from 2011 to 2025. Year-by-year capital reinvestment analysis for NeoGenomics Inc. For the full cash flow conversion analysis, see NeoGenomics Inc (NEO) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 8.90x | $46.57 Million | $5.23 Million | $27.01 Million | ▲ +16.0% |
| 2024 | 7.68x | $53.92 Million | $7.02 Million | $41.06 Million | ▼ -90.8% |
| 2020 | 83.86x | $122.44 Million | $1.46 Million | $29.10 Million | ▲ +4841.7% |
| 2019 | 1.70x | $39.66 Million | $23.37 Million | $20.03 Million | ▼ -50.6% |
| 2018 | 3.44x | $154.00 Million | $44.79 Million | $14.31 Million | ▲ +126.5% |
| 2017 | 1.52x | $27.38 Million | $18.04 Million | $13.69 Million | ▲ +132.3% |
| 2016 | 0.65x | $14.04 Million | $21.48 Million | $7.54 Million | ▲ +88.6% |
| 2015 | 0.35x | $2.21 Million | $6.39 Million | $2.21 Million | ▼ -13.2% |
| 2014 | 0.40x | $3.77 Million | $9.45 Million | $3.77 Million | ▼ -55.8% |
| 2013 | 0.90x | $2.01 Million | $2.23 Million | $2.01 Million | ▼ -93.1% |
| 2011 | 13.00x | $897.00K | $69.00K | $897.00K | — |